Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Glutamatergic nerve cells regularly generated in the brain

Until only a few years ago, neurogenesis - the process of nerve cell development - was considered to be impossible in the adult brain. The textbooks asserted that dead nerve cells could not be replaced. Then researchers discovered regions in the forebrain in humans in which new nerve cells can be generated throughout life. These so-called GABAergic cells use gamma-aminobutyric acid (GABA), a neurotransmitter of the central nervous system.

1 Dec 2009

Brain monitors help avoid postop dementia from routine anesthesia over-medication

To date, hospitals have not found a billing code that insurers will reimburse them for the $20 cost of the disposable sensor for your brain monitor for 'going under' for surgery.

1 Dec 2009

Americans living in the Southern region may have elevated risk of dying from stroke

The "stroke belt" has a tight hold. People born in the Southern stroke belt have a higher risk of dying from stroke as adults, even if they later move away, compared to people who were born in other parts of the country.

1 Dec 2009

Alzheimer's Association offers tips and round the clock assistance for caregivers during holiday season

In Massachusetts, approximately 70% of those with Alzheimer's disease are cared for at home, so the Alzheimer's Association is preparing for a surge in calls to its 24/7 Helpline during the holiday season. For most families, holidays are filled with opportunities for togetherness and sharing, but for a family dealing with Alzheimer's, holidays can also be stressful and filled with special challenges, according to the experts at the Alzheimer's Association.

30 Nov 2009

Bayer Healthcare Pharmaceuticals commences enrollment in florbetaben Phase III clinical trials

Today at the 95th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA), Bayer HealthCare Pharmaceuticals Inc. announced the enrollment of the first patient in an international Phase III clinical trial to evaluate the efficacy and safety of florbetaben (BAY 94-9172) PET imaging in the detection of beta-Amyloid plaques in the brain, which are a pathological hallmark of Alzheimer's disease.

30 Nov 2009

Copper sequestering drug tetrathiomolybdate shown to be effective in treating Wilson disease

The copper sequestering drug tetrathiomolybdate (TM) has been shown in studies to be effective in the treatment of Wilson disease, a disease caused by an overload of copper, and certain metastatic cancers.

27 Nov 2009

Merck, Idera Pharmaceuticals extend their vaccine research collaboration

Idera Pharmaceuticals, Inc. today announced that Merck & Co., Inc., through an affiliate, has extended its research collaboration with Idera for a fourth year. In December 2006, the companies entered into an exclusive license and research collaboration agreement to research, develop, and commercialize vaccine products containing the Company’s investigational agonist compounds targeting Toll-like Receptors (TLRs) 7, 8, and 9 in the fields of oncology, infectious diseases, and Alzheimer’s disease.

26 Nov 2009

Wnt signaling pathway plays a role in diabetic retinopathy

A group led by Dr. Jian-xing Ma at The University of Oklahoma Health Sciences Center, Oklahoma City, OK has demonstrated that the Wnt signaling pathway plays a role in diabetic retinopathy.

26 Nov 2009

Strategies to reduce greenhouse gases benefit human health, show new studies

Today, new studies published in the Lancet show that strategies to reduce greenhouse gases also benefit human health. The Lancet series highlights case studies on four climate change topics - household energy, transportation, electricity generation, and agricultural food production.

26 Nov 2009

Canadian Stroke Network receives $19.2M federal grant

The Canadian Stroke Network, one of Canada's Networks of Centres of Excellence, has received $19.2 million from the federal government over three years to support valuable research into stroke, one of the leading causes of death and disability in Canada.

26 Nov 2009

Dr. Sarit Larisch receives the prestigious Johnson & Johnson Focused Funding grant

Dr. Sarit Larisch, Head of the Cell Death Research Laboratory in the University of Haifa's Department of Biology, has been awarded the prestigious Johnson & Johnson Focused Funding grant for her research exploring the cause of brain cell damage in Parkinson's disease.

26 Nov 2009

Gestion Univalor, Cognitive Sensing to commercialize Prof. Jocelyn Faubert's four products

Cutting-edge technologies are about to enter the marketplace, thanks to a new partnership between Gestion Univalor, Limited Partnership (Univalor) and Cognitive Sensing Inc. (CSI), a privately owned technology company based in Montreal.

25 Nov 2009

Novel way to fight UTIs: Research into Alzheimer's disease

Research into Alzheimer's disease seems an unlikely approach to yield a better way to fight urinary tract infections (UTIs), but that's what scientists at Washington University School of Medicine in St. Louis and elsewhere recently reported.

25 Nov 2009

Johnson & Johnson Focused Funding grant for research on brain cell damage in PD

‏Dr. Sarit Larisch, Head of the Cell Death Research Laboratory and senior lecturer at the University of Haifa, has been awarded the prestigious Johnson & Johnson Focused Funding grant for her research exploring the cause of brain cell damage in Parkinson's disease.

25 Nov 2009

GeckoSystems learns new insights during home care robot trials

GeckoSystems Intl. Corp. (http://www.geckosystems.com/) announced today that during their first week of real world evaluation trials, for their fully autonomous personal companion home care robot, the CareBot™, they have learned some surprising and some, not surprising, insights.

25 Nov 2009

Eisai's NDA for Aricept tablets for treatment of Alzheimer's disease accepted for review

Eisai Inc. and Pfizer Inc announced today that the U.S. Food and Drug Administration (FDA) has accepted for review Eisai's New Drug Application (NDA) for once daily 23 mg Aricept® (donepezil HCl extended release) tablets for the treatment of moderate to severe Alzheimer's disease (AD).

25 Nov 2009

Alzheimer's disease research leads to more effective UTI treatments

24 Nov 2009

Innovation Award for GMI presented at the 2009 World Congress on Medical Physics

Gamma Medica-Ideas, Inc., a leading developer of digital molecular imaging systems, announced today that it has been awarded an Innovation Award for its new prototype imaging system that combines the molecular imaging (MI) capability of single-photon nuclear imaging with magnetic resonance imaging (MRI). The award was presented to GMI at the 2009 World Congress on Medical Physics and Biomedical Engineering in Munich, Germany that took place on September 7th, 2009.

24 Nov 2009

Update from GeckoSystems regarding its CareBot elder care robot

GeckoSystems Intl. Corp. announced today that since their first annual "Mobile Robots in Motion" conference earlier this month, they have been solicited by another first tier contract manufacturer interested in the high volume manufacture of their product line. GeckoSystems is a dynamic leader in the emerging Mobile Service Robot industry revolutionizing their development and usage with "Mobile Robot Solutions for Safety, Security and Service™."

24 Nov 2009

New findings shake the foundations of Alzheimer's research

Alzheimer's disease is caused by the build-up of a brain peptide called amyloid-beta. That's why eliminating the protein has been the focus of almost all drug research pursuing a cure for the devastating neurodegenerative condition.

24 Nov 2009

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Glutamatergic nerve cells regularly generated in the brain

Brain monitors help avoid postop dementia from routine anesthesia over-medication

Americans living in the Southern region may have elevated risk of dying from stroke

Alzheimer's Association offers tips and round the clock assistance for caregivers during holiday season

Bayer Healthcare Pharmaceuticals commences enrollment in florbetaben Phase III clinical trials

Copper sequestering drug tetrathiomolybdate shown to be effective in treating Wilson disease

Merck, Idera Pharmaceuticals extend their vaccine research collaboration

Wnt signaling pathway plays a role in diabetic retinopathy

Strategies to reduce greenhouse gases benefit human health, show new studies

Canadian Stroke Network receives $19.2M federal grant

Dr. Sarit Larisch receives the prestigious Johnson & Johnson Focused Funding grant

Gestion Univalor, Cognitive Sensing to commercialize Prof. Jocelyn Faubert's four products

Novel way to fight UTIs: Research into Alzheimer's disease

Johnson & Johnson Focused Funding grant for research on brain cell damage in PD

GeckoSystems learns new insights during home care robot trials

Eisai's NDA for Aricept tablets for treatment of Alzheimer's disease accepted for review

Alzheimer's disease research leads to more effective UTI treatments

Innovation Award for GMI presented at the 2009 World Congress on Medical Physics

Update from GeckoSystems regarding its CareBot elder care robot

New findings shake the foundations of Alzheimer's research

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Newsletters you may be interested in